Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.

IF 2.2 4区 医学 Q3 CHEMISTRY, MULTIDISCIPLINARY
Ertan Katirci, Remziye Kendirci-Katirci, Suna Karadeniz-Saygili, Nureddin Cengiz
{"title":"Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.","authors":"Ertan Katirci, Remziye Kendirci-Katirci, Suna Karadeniz-Saygili, Nureddin Cengiz","doi":"10.1080/01480545.2026.2751435","DOIUrl":null,"url":null,"abstract":"<p><p>Ovarian cancer remains a major cause of death among gynecologic malignancies because of late diagnosis, frequent recurrence, and resistance to standard chemotherapy. Drug repurposing offers a cost-effective strategy for identifying alternative therapeutic agents, but the comparative toxicodynamic effects of fenbendazole in malignant and nonmalignant ovarian cell models remain incompletely characterized. In this study, the toxicodynamic effects of fenbendazole were evaluated in malignant ovarian cell lines (OVCAR8 and A2780) and compared with those in a nonmalignant ovarian epithelial comparator (IOSE-80) using integrated <i>in vitro</i> approaches, with exploratory <i>in silico</i> analysis as supportive structural context. Fenbendazole reduced viability in ovarian cancer cells in a time- and concentration-dependent manner. At 72 h, IC<sub>50</sub> values were lowest in A2780, intermediate in OVCAR8, and remained above the tested concentration range in IOSE-80, yielding lower-bound selectivity indices in favor of malignant cells. Fenbendazole also increased G2/M accumulation, γ-H2AX and cleaved caspase-3 signals, and Annexin V-positive cell populations in malignant cells. These findings indicate that fenbendazole exerts preferential toxicodynamic effects in malignant ovarian cell models relative to the nonmalignant comparator used in this study. An exploratory molecular docking analysis provided limited supportive structural context for a possible tubulin-related mechanism but was not interpreted as evidence of direct target engagement.</p>","PeriodicalId":11333,"journal":{"name":"Drug and Chemical Toxicology","volume":" ","pages":"1-10"},"PeriodicalIF":2.2000,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Chemical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/01480545.2026.2751435","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Ovarian cancer remains a major cause of death among gynecologic malignancies because of late diagnosis, frequent recurrence, and resistance to standard chemotherapy. Drug repurposing offers a cost-effective strategy for identifying alternative therapeutic agents, but the comparative toxicodynamic effects of fenbendazole in malignant and nonmalignant ovarian cell models remain incompletely characterized. In this study, the toxicodynamic effects of fenbendazole were evaluated in malignant ovarian cell lines (OVCAR8 and A2780) and compared with those in a nonmalignant ovarian epithelial comparator (IOSE-80) using integrated in vitro approaches, with exploratory in silico analysis as supportive structural context. Fenbendazole reduced viability in ovarian cancer cells in a time- and concentration-dependent manner. At 72 h, IC50 values were lowest in A2780, intermediate in OVCAR8, and remained above the tested concentration range in IOSE-80, yielding lower-bound selectivity indices in favor of malignant cells. Fenbendazole also increased G2/M accumulation, γ-H2AX and cleaved caspase-3 signals, and Annexin V-positive cell populations in malignant cells. These findings indicate that fenbendazole exerts preferential toxicodynamic effects in malignant ovarian cell models relative to the nonmalignant comparator used in this study. An exploratory molecular docking analysis provided limited supportive structural context for a possible tubulin-related mechanism but was not interpreted as evidence of direct target engagement.

芬苯达唑在卵巢癌和非恶性卵巢细胞模型中的优先毒理学效应。
卵巢癌仍然是妇科恶性肿瘤的主要死亡原因,因为诊断晚,复发频繁,以及对标准化疗的抵抗。药物再利用为确定替代治疗药物提供了一种具有成本效益的策略,但芬苯达唑在恶性和非恶性卵巢细胞模型中的比较毒理学效应仍未完全表征。在这项研究中,采用综合体外方法评估了芬苯达唑在恶性卵巢细胞系(OVCAR8和A2780)中的毒理学效应,并将其与非恶性卵巢上皮比较物(IOSE-80)中的毒理学效应进行了比较,探索性硅分析作为支持结构背景。芬苯达唑以时间和浓度依赖的方式降低卵巢癌细胞的活力。72h时,A2780的IC50值最低,OVCAR8的IC50值居中,而IOSE-80的IC50值仍高于测试浓度范围,产生有利于恶性细胞的下限选择性指数。芬苯达唑还增加了恶性细胞的G2/M积累、γ-H2AX和裂解caspase-3信号以及Annexin v阳性细胞群。这些发现表明,相对于本研究中使用的非恶性比较物,芬苯达唑在恶性卵巢细胞模型中具有优先的毒理学效应。探索性分子对接分析为可能的微管蛋白相关机制提供了有限的支持结构背景,但不能解释为直接靶向作用的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug and Chemical Toxicology
Drug and Chemical Toxicology 医学-毒理学
CiteScore
6.00
自引率
3.80%
发文量
99
审稿时长
3 months
期刊介绍: Drug and Chemical Toxicology publishes full-length research papers, review articles and short communications that encompass a broad spectrum of toxicological data surrounding risk assessment and harmful exposure. Manuscripts are considered according to their relevance to the journal. Topics include both descriptive and mechanics research that illustrates the risk assessment implications of exposure to toxic agents. Examples of suitable topics include toxicological studies, which are structural examinations on the effects of dose, metabolism, and statistical or mechanism-based approaches to risk assessment. New findings and methods, along with safety evaluations, are also acceptable. Special issues may be reserved to publish symposium summaries, reviews in toxicology, and overviews of the practical interpretation and application of toxicological data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书